| Report ID | Date of report | Patient age | Patient gender |
| 72077 | Mar, 16, 2006 | 59 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Vioxx | rofecoxib |
Norvasc | amlodipine besylate |
Vasotec Rpd | enalapril maleate |
Glucophage | metformin hydrochloride |
Hytrin | terazosin hydrochloride |
Trimox | amoxicillin |
| Name |
Acute Myocardial Infarction |
Aortic Calcification |
Arteriosclerosis |
Cardiomegaly |
Contusion |
Coronary Artery Stenosis |
Coronary Artery Thrombosis |
Diabetes Mellitus Inadequate Control |
Hepatic Congestion |
Hepatic Steatosis |
Hepatomegaly |
Myocardial Rupture |
Nephrosclerosis |
Osteoporosis |
Pericardial Haemorrhage |
Polycystic Ovaries |
Pulmonary Congestion |
Renal Disorder |
Road Traffic Accident |
Skin Depigmentation |
Spleen Congestion |
Results from eHealthMe : 18 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Acute Myocardial Infarction | 18 (100.00%) |
Aortic Calcification | 18 (100.00%) |
Arteriosclerosis | 12 (66.67%) |
Cardiomegaly | 18 (100.00%) |
Contusion | 18 (100.00%) |
Coronary Artery Stenosis | 18 (100.00%) |
Coronary Artery Thrombosis | 18 (100.00%) |
Diabetes Mellitus Inadequate Control | 16 (88.89%) |
Hepatic Congestion | 18 (100.00%) |
Hepatic Steatosis | 18 (100.00%) |
Hepatomegaly | 18 (100.00%) |
Myocardial Rupture | 18 (100.00%) |
Nephrosclerosis | 18 (100.00%) |
Osteoporosis | 16 (88.89%) |
Pericardial Haemorrhage | 18 (100.00%) |
Polycystic Ovaries | 18 (100.00%) |
Pulmonary Congestion | 18 (100.00%) |
Renal Disorder | 18 (100.00%) |
Road Traffic Accident | 18 (100.00%) |
Skin Depigmentation | 16 (88.89%) |
Spleen Congestion | 18 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Pericardial Haemorrhage | 18 (100.00%) |
Acute Myocardial Infarction | 18 (100.00%) |
Myocardial Rupture | 18 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
